INDIAGLYCO
India Glycols Limited
India Glycols Limited (INDIAGLYCO) financial statements and selected valuation metrics through 30 June 2026.
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Beverages›Breweries & Distilleries
indiaglycols.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-19
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
India Glycols makes bio-based glycols, green solvents and performance chemicals (plus industrial gases) for industrial users.
Company snapshot
8thBy market cap
Ranked among 15 companies in Breweries & Distilleries.
Segment mix
Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.
Largest segment: 70.4% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Bio-Fuel | 11.2% | 770 Cr | 41 Cr | — |
| Bio-based Specialities and Performance Chemicals | 15.9% | 1,088 Cr | 96 Cr | — |
| Ennature Biopharma | 2.4% | 168 Cr | 16 Cr | — |
| Potable Spirits | 70.4% | 4,824 Cr | 178 Cr | — |
What we see
- ✓100% of operating profit came in as cash over the last three years — profits are backed by real cash.
- ✗Net margin is very thin at 3.0% — little room for error if costs rise.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,870 Cr | 2,119 Cr | 2,039 Cr | 2,283 Cr | 2,144 Cr | 2,424 Cr | 2,189 Cr | 2,503 Cr | 2,412 Cr | 2,551 Cr | 2,360 Cr | 2,988 Cr |
| Operating expenses (approx.) | 1,774 Cr | 2,017 Cr | 1,935 Cr | 2,157 Cr | 2,028 Cr | 2,300 Cr | 2,043 Cr | 2,353 Cr | 2,255 Cr | 2,376 Cr | 2,194 Cr | 2,819 Cr |
| EBITDA | 96 Cr | 102 Cr | 105 Cr | 126 Cr | 116 Cr | 124 Cr | 146 Cr | 150 Cr | 158 Cr | 175 Cr | 167 Cr | 170 Cr |
| OPM % | 5.1% | 4.8% | 5.1% | 5.5% | 5.4% | 5.1% | 6.7% | 6.0% | 6.5% | 6.9% | 7.1% | 5.7% |
| Other income | 11 Cr | 5 Cr | 5 Cr | 3 Cr | 4 Cr | 6 Cr | 2 Cr | 1 Cr | 2 Cr | 0.74 Cr | 0.62 Cr | 0.38 Cr |
| Interest | 29 Cr | 31 Cr | 33 Cr | 36 Cr | 40 Cr | 44 Cr | 45 Cr | 45 Cr | 49 Cr | 47 Cr | 26 Cr | 25 Cr |
| Depreciation | 28 Cr | 26 Cr | 26 Cr | 28 Cr | 28 Cr | 27 Cr | 33 Cr | 34 Cr | 38 Cr | 41 Cr | 41 Cr | 42 Cr |
| Profit before tax | 50 Cr | 54 Cr | 56 Cr | 76 Cr | 63 Cr | 71 Cr | 82 Cr | 91 Cr | 84 Cr | 91 Cr | 112 Cr | 123 Cr |
| Tax % | 24.1% | 22.8% | 24.1% | 20.2% | 21.7% | 20.5% | 21.7% | 19.1% | 22.2% | 25.4% | 22.7% | 21.2% |
| Net profit | 38 Cr | 42 Cr | 42 Cr | 60 Cr | 50 Cr | 57 Cr | 64 Cr | 73 Cr | 65 Cr | 68 Cr | 87 Cr | 97 Cr |
| EPS (₹) | ₹12.27 | ₹13.45 | ₹13.63 | ₹19.50 | ₹16.06 | ₹18.35 | ₹20.68 | ₹23.66 | ₹10.51 | ₹10.79 | ₹13.64 | ₹14.45 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,609 Cr | 4,162 Cr | 5,117 Cr | 5,973 Cr | 5,427 Cr | 6,601 Cr | 6,642 Cr | 7,922 Cr | 9,039 Cr | 9,827 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 3,373 Cr | 3,838 Cr | 4,701 Cr | 5,581 Cr | 5,159 Cr | 6,346 Cr | 6,346 Cr | 7,519 Cr | 8,528 Cr | 9,177 Cr | Sign in free for the trailing twelve months |
| EBITDA | 236 Cr | 324 Cr | 417 Cr | 392 Cr | 268 Cr | 255 Cr | 296 Cr | 402 Cr | 511 Cr | 649 Cr | Sign in free for the trailing twelve months |
| OPM % | 6.5% | 7.8% | 8.1% | 6.6% | 4.9% | 3.9% | 4.4% | 5.1% | 5.7% | 6.6% | Sign in free for the trailing twelve months |
| Other income | 8 Cr | 23 Cr | 17 Cr | 9 Cr | 15 Cr | 22 Cr | 24 Cr | 26 Cr | 15 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Interest | 127 Cr | 125 Cr | 143 Cr | 143 Cr | 83 Cr | 70 Cr | 100 Cr | 121 Cr | 164 Cr | 167 Cr | Sign in free for the trailing twelve months |
| Depreciation | 72 Cr | 73 Cr | 76 Cr | 83 Cr | 80 Cr | 80 Cr | 94 Cr | 101 Cr | 115 Cr | 155 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 45 Cr | 147 Cr | 213 Cr | 174 Cr | 166 Cr | 383 Cr | 165 Cr | 223 Cr | 292 Cr | 377 Cr | Sign in free for the trailing twelve months |
| Tax % | 22.1% | 34.4% | 37.8% | 34.1% | 20.6% | 11.2% | 14.5% | 22.5% | 21.0% | 22.4% | Sign in free for the trailing twelve months |
| Net profit | 35 Cr | 97 Cr | 133 Cr | 115 Cr | 132 Cr | 340 Cr | 141 Cr | 173 Cr | 231 Cr | 293 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹11.32 | ₹31.18 | ₹42.83 | ₹37.03 | ₹42.51 | ₹109.77 | ₹45.55 | ₹55.87 | ₹74.58 | ₹45.95 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 0.3% | 5.4% | 16.3% | 13.3% | 10.6% | 25.7% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 31 Cr | 31 Cr | 31 Cr | 31 Cr | 31 Cr | 31 Cr | 31 Cr | 31 Cr | 31 Cr | 34 Cr |
| Reserves | 721 Cr | 814 Cr | 932 Cr | 1,003 Cr | 1,138 Cr | 1,761 Cr | 1,870 Cr | 2,020 Cr | 2,225 Cr | 2,899 Cr |
| Borrowings | 945 Cr | 751 Cr | 863 Cr | 891 Cr | 991 Cr | 1,040 Cr | 1,094 Cr | 1,321 Cr | 1,804 Cr | 1,578 Cr |
| Other liabilities | 1,795 Cr | 1,825 Cr | 1,959 Cr | 2,161 Cr | 1,960 Cr | 1,818 Cr | 1,863 Cr | 2,245 Cr | 2,116 Cr | 2,012 Cr |
| Total liabilities | 3,492 Cr | 3,421 Cr | 3,784 Cr | 4,086 Cr | 4,119 Cr | 4,631 Cr | 4,858 Cr | 5,617 Cr | 6,176 Cr | 6,523 Cr |
| Fixed assets (net) | 2,110 Cr | 2,155 Cr | 2,165 Cr | 2,218 Cr | 2,183 Cr | 2,309 Cr | 2,707 Cr | 3,197 Cr | 3,826 Cr | 4,551 Cr |
| CWIP | 91 Cr | 89 Cr | 137 Cr | 172 Cr | 126 Cr | 243 Cr | 125 Cr | 84 Cr | 98 Cr | 37 Cr |
| Investments | 25 Cr | 24 Cr | 30 Cr | 34 Cr | 35 Cr | 344 Cr | 326 Cr | 342 Cr | 383 Cr | 391 Cr |
| Loans & advances | — | — | 26 Cr | 26 Cr | 25 Cr | 25 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 518 Cr | 448 Cr | 647 Cr | 682 Cr | 610 Cr | 693 Cr | 754 Cr | 1,106 Cr | 1,171 Cr | 891 Cr |
| Trade receivables | 390 Cr | 334 Cr | 322 Cr | 569 Cr | 362 Cr | 399 Cr | 430 Cr | 384 Cr | 365 Cr | 351 Cr |
| Cash & bank | 5 Cr | 5 Cr | 27 Cr | 4 Cr | 3 Cr | 7 Cr | 2 Cr | 27 Cr | 7 Cr | 32 Cr |
| Other assets | 352 Cr | 366 Cr | 431 Cr | 382 Cr | 775 Cr | 611 Cr | 514 Cr | 477 Cr | 326 Cr | 271 Cr |
| Total assets | 3,492 Cr | 3,421 Cr | 3,784 Cr | 4,086 Cr | 4,119 Cr | 4,631 Cr | 4,858 Cr | 5,617 Cr | 6,176 Cr | 6,523 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 302 Cr | 502 Cr | 147 Cr | 343 Cr | 81 Cr | 91 Cr | 326 Cr | 439 Cr | 362 Cr | 769 Cr |
| Cash from investing | -40 Cr | -103 Cr | -128 Cr | -151 Cr | -131 Cr | 93 Cr | -330 Cr | -503 Cr | -736 Cr | -767 Cr |
| Cash from financing | -263 Cr | -399 Cr | 3 Cr | -216 Cr | 49 Cr | -181 Cr | -0.51 Cr | 90 Cr | 354 Cr | 23 Cr |
| Net cash flow | -0.92 Cr | -0.47 Cr | 22 Cr | -23 Cr | -0.26 Cr | 4 Cr | -5 Cr | 25 Cr | -20 Cr | 25 Cr |
| Free cash flow (OCF − Capex) | 260 Cr | 372 Cr | 8 Cr | 188 Cr | -68 Cr | -288 Cr | -113 Cr | -114 Cr | -398 Cr | -54 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 10.1% | 17.1% | 19.5% | 16.5% | 11.5% | 16.1% | 8.8% | 10.2% | 11.2% | 12.1% |
| ROE % | 4.7% | 11.4% | 13.8% | 11.1% | 11.3% | 19.2% | 6.6% | 8.4% | 10.2% | 10.0% |
| Debtor days | 39 | 29 | 23 | 35 | 24 | 22 | 24 | 18 | 15 | 13 |
| Inventory days | 153 | 114 | 152 | 148 | 187 | 151 | 190 | 222 | 182 | 134 |
| Days payable | 171 | 198 | 175 | 156 | 178 | 140 | 189 | 221 | 152 | 119 |
| Cash conversion cycle | 21 | -55 | 0 | 26 | 33 | 33 | 24 | 19 | 44 | 29 |
| OCF / EBITDA % | 127.9% | 155.1% | 35.3% | 87.6% | 30.3% | 35.8% | 110.2% | 109.0% | 70.9% | 118.5% |
| OCF / EBITDA % (3 years) | — | — | 97.4% | 87.6% | 53.1% | 56.4% | 60.9% | 89.8% | 93.2% | 100.5% |
| Debt / equity | 1.26 | 0.89 | 0.90 | 0.86 | 0.85 | 0.59 | 0.58 | 0.64 | 0.80 | 0.54 |
| Current ratio | 0.59 | 0.65 | 0.80 | 0.80 | 0.77 | 0.92 | 0.88 | 0.82 | 0.78 | 0.74 |
| Net debt / EBITDA | 3.97 | — | 2.00 | 2.27 | 3.69 | 4.05 | 3.70 | 3.22 | 3.52 | 2.38 |